Company news
Solid Biosciences Inc. news in 2022
Solid Biosciences Inc.'s news releases, calls and decks from 2022, newest first.
Solid Biosciences Announces Closing of Acquisition of AavantiBio and Concurrent $75 Million Private Placement
December 4, 2022
Solid Biosciences Announces Stockholder Approval of Acquisition of AavantiBio
November 30, 2022
Solid Biosciences Provides Third Quarter 2022 Business Update and Financial Results
November 9, 2022
Solid Biosciences Announces a 1-for-15 Reverse Stock Split
October 26, 2022
Solid Biosciences Announces Acquisition of AavantiBio and Concurrent $75 Million Private Placement
September 29, 2022
Solid Biosciences Provides Second Quarter 2022 Business Update and Financial Results
August 10, 2022
Solid Biosciences Reports Inducement Grant to New Senior Vice President, Quality
June 1, 2022
Solid Biosciences Announces Updated Corporate Strategy to Develop SGT-001 and SGT-003 Pipeline Programs for Patients with Duchenne Muscular Dystrophy
April 26, 2022
Solid Biosciences Reports Fourth Quarter and Full-Year 2021 Financial Results and 2-Year Efficacy and Safety Data from the Ongoing Phase I/II IGNITE DMD Clinical Trial of SGT-001
March 13, 2022
Solid Biosciences Outlines its Strategic Priorities for 2022 and Announces Corporate Updates
January 9, 2022
Solid Biosciences Reports Inducement Grant to New Senior Vice President, Human Resources
January 3, 2022
Calls in 2022
Decks in 2022
- Merger or Acquisition (September 2022)
Merger or acquisition · 31 slides · Sep 30, 2022